Page last updated: 2024-09-04

abiraterone and Neuroendocrine Tumors

abiraterone has been researched along with Neuroendocrine Tumors in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aggarwal, R; Behrens, CR; Bidlingmaier, S; Burlingame, AL; Hann, BC; Lee, NK; Liu, B; Liu, Y; Paris, PL; Premasekharan, G; Seo, Y; Sherbenou, DW; Shuman, MA; Simko, JP; Small, EJ; Su, Y	1

Other Studies

1 other study(ies) available for abiraterone and Neuroendocrine Tumors

Article	Year
Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer. JCI insight, 2018, 09-06, Volume: 3, Issue:17 Topics: Adenocarcinoma; Androstenes; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Affinity; Antigens, Neoplasm; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Female; Humans; Macaca fascicularis; Male; Membrane Cofactor Protein; Neuroendocrine Tumors; Nitriles; Phenylthiohydantoin; Prostate; Prostatic Neoplasms; Recombinant Fusion Proteins; Signal Transduction; Therapeutics; Tumor Microenvironment; Xenograft Model Antitumor Assays	2018

Article

Year

Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer.

JCI insight, 2018, 09-06, Volume: 3, Issue:17

Topics: Adenocarcinoma; Androstenes; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Affinity; Antigens, Neoplasm; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Female; Humans; Macaca fascicularis; Male; Membrane Cofactor Protein; Neuroendocrine Tumors; Nitriles; Phenylthiohydantoin; Prostate; Prostatic Neoplasms; Recombinant Fusion Proteins; Signal Transduction; Therapeutics; Tumor Microenvironment; Xenograft Model Antitumor Assays

2018